diff --git a/wiki/pages/model.html b/wiki/pages/model.html
index 2ec9152493e243d6f7f393fa5a3215e3b9e5b257..fc02d602f450fcaa52c21be86e0118be4ab6bd39 100644
--- a/wiki/pages/model.html
+++ b/wiki/pages/model.html
@@ -2009,12 +2009,12 @@ hold off;</div>
         <div class="col-lg-12">
             <h2 id="References">
             <h2>References</h2>
-            <p>[1] Borghardt JM, Weber B, Staab A, Kloft C. Pharmacometric Models for Characterizing the Pharmacokinetics of Orally Inhaled Drugs. AAPS J. 2015 Jul;17(4):853-70. doi: 10.1208/s12248-015-9760-6. Epub 2015 Apr 7. PMID: 25845315; PMCID: PMC4477002.</p>
-            <p>[2] Thomson TM, Benjamin KR, Bush A, Love T, Pincus D, Resnekov O, Yu RC, Gordon A, Colman-Lerner A, Endy D, Brent R. Scaffold number in yeast signaling system sets tradeoff between system output and dynamic range. Proc Natl Acad Sci U S A. 2011 Dec 13;108(50):20265-70. doi: 10.1073/pnas.1004042108. Epub 2011 Nov 23. PMID: 22114196; PMCID: PMC3250143.</p>
-            <p>[3] Sheng Li. Global quantitative study on the non-equilibrium cell fate decision-making of yeast under pheromone perturbation[D].Jilin University,2023.DOI:10.27162/d.cnki.gjlin.2023.007553.</p>
-            <p>[4] Scott BM, Gutiérrez-Vázquez C, Sanmarco LM, da Silva Pereira JA, Li Z, Plasencia A, Hewson P, Cox LM, O'Brien M, Chen SK, Moraes-Vieira PM, Chang BSW, Peisajovich SG, Quintana FJ. Self-tunable engineered yeast probiotics for the treatment of inflammatory bowel disease. Nat Med. 2021 Jul;27(7):1212-1222. doi: 10.1038/s41591-021-01390-x. Epub 2021 Jun 28. PMID: 34183837.</p>
-            <p>[5] Tuncbag N, Braunstein A, Pagnani A, Huang SS, Chayes J, Borgs C, Zecchina R, Fraenkel E. Simultaneous reconstruction of multiple signaling pathways via the prize-collecting steiner forest problem. J Comput Biol. 2013 Feb;20(2):124-36. doi: 10.1089/cmb.2012.0092. PMID: 23383998; PMCID: PMC3576906.</p>
-            <p>[6] Kanehisa, M. (n.d.). Pathway: Sce04011. KEGG. Retrieved October 1, 2024, from https://www.kegg.jp/pathway/sce04011</p>
+            <p style="font-size: 0.7em;">[1] Borghardt JM, Weber B, Staab A, Kloft C. Pharmacometric Models for Characterizing the Pharmacokinetics of Orally Inhaled Drugs. AAPS J. 2015 Jul;17(4):853-70. doi: 10.1208/s12248-015-9760-6. Epub 2015 Apr 7. PMID: 25845315; PMCID: PMC4477002.</p>
+            <p style="font-size: 0.7em;">[2] Thomson TM, Benjamin KR, Bush A, Love T, Pincus D, Resnekov O, Yu RC, Gordon A, Colman-Lerner A, Endy D, Brent R. Scaffold number in yeast signaling system sets tradeoff between system output and dynamic range. Proc Natl Acad Sci U S A. 2011 Dec 13;108(50):20265-70. doi: 10.1073/pnas.1004042108. Epub 2011 Nov 23. PMID: 22114196; PMCID: PMC3250143.</p>
+            <p style="font-size: 0.7em;">[3] Sheng Li. Global quantitative study on the non-equilibrium cell fate decision-making of yeast under pheromone perturbation[D].Jilin University,2023.DOI:10.27162/d.cnki.gjlin.2023.007553.</p>
+            <p style="font-size: 0.7em;">[4] Scott BM, Gutiérrez-Vázquez C, Sanmarco LM, da Silva Pereira JA, Li Z, Plasencia A, Hewson P, Cox LM, O'Brien M, Chen SK, Moraes-Vieira PM, Chang BSW, Peisajovich SG, Quintana FJ. Self-tunable engineered yeast probiotics for the treatment of inflammatory bowel disease. Nat Med. 2021 Jul;27(7):1212-1222. doi: 10.1038/s41591-021-01390-x. Epub 2021 Jun 28. PMID: 34183837.</p>
+            <p style="font-size: 0.7em;">[5] Tuncbag N, Braunstein A, Pagnani A, Huang SS, Chayes J, Borgs C, Zecchina R, Fraenkel E. Simultaneous reconstruction of multiple signaling pathways via the prize-collecting steiner forest problem. J Comput Biol. 2013 Feb;20(2):124-36. doi: 10.1089/cmb.2012.0092. PMID: 23383998; PMCID: PMC3576906.</p>
+            <p style="font-size: 0.7em;">[6] Kanehisa, M. (n.d.). Pathway: Sce04011. KEGG. Retrieved October 1, 2024, from https://www.kegg.jp/pathway/sce04011</p>
             <hr>
         </div>
     </div>